Andrew Vyse | Medicine | Excellence Award (Any Scientific field)

Dr. Andrew Vyse | Medicine | Excellence Award (Any Scientific field)

Epidemiologist | Pfizer UK Ltd | United Kingdom

Dr. Andrew Vyse is a seasoned epidemiologist with extensive experience in both the pharmaceutical industry and public health research. He specializes in vaccine-preventable and potentially vaccine-preventable infections, contributing significantly to the field with over 80 peer-reviewed publications.

Profile

Scopus

Strengths for the Awards

  • Prolific Research Contributions:
    • Dr. Vyse has authored over 80 peer-reviewed publications, which demonstrates a consistent and significant contribution to epidemiological research, particularly in the area of vaccine-preventable diseases.
    • Recent publications cover diverse, critical topics such as Lyme disease, pneumococcal vaccination, RSV, and cost-effectiveness of vaccine strategies. This breadth indicates a comprehensive understanding of the field.
  • Impact on Public Health:
    • His work in vaccine-preventable diseases directly contributes to public health improvements, including informing vaccination strategies and addressing vaccine-preventable hospitalizations.
  • Industry and Academic Experience:
    • A balance of pharmaceutical industry experience (Pfizer and GSK) and public health research (UKHSA) highlights his ability to bridge scientific research with practical applications.
    • This unique positioning allows him to contribute to both policy-making and the development of new vaccine technologies.

Education 🎓

Dr. Vyse holds a PhD and MSc, reflecting his robust academic foundation in epidemiology and public health. His educational background has equipped him with the expertise to drive impactful research and clinical applications in his field.

Professional Experience 💼

  • Feb 2017 – Present: Clinical Epidemiologist at Pfizer UK Ltd, supporting the UK Medical Team and global Scientific Affairs for vaccines including pneumococcal, RSV, COVID, meningococcal, and a candidate Lyme vaccine.
  • Jan 2009 – Jan 2017: Global Epidemiologist at GSK Vaccines, contributing to portfolios for meningococcal, DTP, and rotavirus vaccines.
  • May 1993 – Dec 2008: Clinical Scientist at the UK Health Security Agency (formerly Public Health England), focusing on surveillance and epidemiological research for vaccine-preventable infections.

Research Interests On Medicine 🧬

Dr. Vyse’s research interests revolve around vaccine-preventable diseases, with a particular focus on respiratory infections, Lyme borreliosis, and strategies to optimize vaccination coverage in vulnerable populations.

Awards and Recognition 🏆

Dr. Vyse has been recognized for his contributions to epidemiology and vaccine research. His work has garnered significant academic and industry accolades, reflecting his impact on public health initiatives and vaccine development.

Publications 🔖

1. Estimating adult accident and emergency attendances in English hospitals attributed to respiratory syncytial virus

  • Authors: Vyse, A., Wright, H., Begier, E.
  • Year: 2024
  • Citations: 0

2. Using Catalytic Models to Interpret Age-Stratified Lyme Borreliosis Seroprevalence Data

  • Authors: Vyse, A., Colby, E.
  • Year: 2024
  • Citations: 0

3. Incidence of symptomatic Lyme borreliosis in nine European countries

  • Authors: Angulo, F.J., Colby, E., Lebech, A.-M., Moïsi, J.C., Stark, J.H.
  • Year: 2024
  • Citations: 1

4. Adult risk groups for vaccine-preventable respiratory infections: an overview of the UK environment

  • Authors: Reynard, C., Campling, J., Gordon, A.L., Wright, H., Ellsbury, G.
  • Year: 2024
  • Citations: 0

5. Estimating the Cost-Effectiveness of Switching to Higher-Valency Pediatric Pneumococcal Conjugate Vaccines in the United Kingdom

  • Authors: Wilson, M., Lucas, A., Mendes, D., Ellsbury, G.F., Perdrizet, J.
  • Year: 2023
  • Citations: 9

6. Assessing the Role of Infant and Toddler MenACWY Immunisation in the UK

  • Authors: Schley, K., Kowalik, J.C., Sullivan, S.M., Tichy, E., Findlow, J.
  • Year: 2023
  • Citations: 0

7. Vaccine-Preventable Hospitalisations from Seasonal Respiratory Diseases: What Is Their True Value?

  • Authors: Neri, M., Brassel, S., Schirrmacher, H., Steuten, L., Hamson, E.
  • Year: 2023
  • Citations: 4

8. A Retrospective Database Study of Lyme Borreliosis Incidence in Poland from 2015 to 2019

  • Authors: Paradowska-Stankiewicz, I., Zbrzezniak, J., Skufca, J., Gessner, B.D., Stark, J.H.
  • Year: 2023
  • Citations: 5

9. Incidence of Lyme Borreliosis in Germany

  • Authors: Skufca, J., Tran, T.M.P., Brestrich, G., Gessner, B.D., Stark, J.H.
  • Year: 2023
  • Citations: 2

10. Incidence of Lyme Borreliosis in the Dutch General Practice Population

  • Authors: Houben, E., De Jong, H., Penning-Van Beest, F., Herings, R., Stark, J.H.
  • Year: 2023
  • Citations: 3

Conclusion 🌐

Dr. Andrew Vyse’s work bridges the pharmaceutical industry and public health research, driving innovations in vaccine development and disease prevention. His dedication to epidemiology continues to advance global health outcomes, underpinned by his extensive research, impactful publications, and commitment to public health initiatives.

Tadeusz Dobosz | Molecular Medicine | Best Researcher Award

Prof. Tadeusz Dobosz | Molecular Medicine | Best Researcher Award

Retired | University of Medicine Wroclaw | Poland

Tadeusz Dobosz, is a distinguished medical scientist and forensic geneticist. Married with two children, he has made significant contributions to the fields of molecular biology, medical genetics, and forensic science. A retired professor, Dobosz is known for his expertise in DNA technologies, paternity testing, and seroanthropology. He has authored over 75 publications on the Philadelphia List, 515 additional papers, and oral presentations with a Hirsch Index of 20. Currently, he is focused on developing a Museum of Medicine.

Profile

Scopus

Orcid

Strenghts for the Awards

  1. Extensive Academic and Professional Experience:
    • Over 49 years of professional engagement in biochemistry, molecular biology, forensic genetics, and medical genetics.
    • Progression from Assistant to University Professor and Head of the Molecular Techniques Unit at the Medical University of Wrocław.
    • Leadership roles in establishing and managing research laboratories, including Molecular Medicine, Paternity Testing, Forensic Genetics, and Seroanthropology.
  2. Research Contributions:
    • Authored 75 publications indexed in the Philadelphia List and over 515 additional papers, oral presentations, and posters.
    • Hirsch Index of 20, indicating a significant impact on the scientific community.
    • Expertise in cutting-edge forensic and genetic technologies, including PCR, SNP analysis, and DNA sequencing.
  3. Pioneering Work in Forensic Science and Genetics:
    • Specializes in human remains identification, ancient DNA (aDNA) research, and non-destructive DNA extraction methods.
    • Innovations in seroanthropology and forensic ballistics, including DNA deposits on weapons, cases, and bullets.
    • Contributions to paternity testing and biological trace investigations.
  4. Legacy and Knowledge Sharing:
    • Continuation of professional contributions post-retirement by organizing a Museum of Medicine and Hospital Museum.
    • A mentor and guide to the next generation of researchers in the Molecular Techniques Unit.
  5. Interdisciplinary Research Interests:
    • Combines molecular genetics with medical diagnostics, forensic ballistics, and even museology, showcasing a holistic and diverse approach to science.

Education 🎓

  • 1963: Graduated from Primary School.
  • 1967: Completed High School.
  • 1971: Earned a degree in Biochemistry from the University of Wrocław.
  • 1977: Achieved a Ph.D. in Immunology.
  • 2001: Obtained Habilitation in Medical Genetics.
  • 2007: Awarded the title of University Professor in Medical Science.

Experience 💼

Tadeusz Dobosz’s career spans diverse roles in biochemistry, immunology, and forensic science:

  • 1971-1974: Ph.D. student and Assistant at the Polish Academy of Sciences.
  • 1975: Expert in the Police Laboratory of Criminalistics.
  • 1979: Lecturer at the Medical University, Department of Forensic Medicine, Wrocław.
  • 2002: Senior Lecturer at the Medical University of Wrocław.
  • 2004-2020: Head of the Molecular Techniques Unit, leading four specialized laboratories in Molecular Medicine, Paternity Testing, Forensic Genetics, and Seroanthropology.
  • 2020: Retired and now actively organizes the Museum of Medicine.

Research Interests 🔬

Professor Dobosz specializes in:

  • Forensic genetics and human remains identification.
  • Ancient DNA (aDNA) preparation, repair, and testing.
  • Non-destructive DNA isolation methods from valuable specimens.
  • DNA computing and forensic ballistics (e.g., DNA traces on weapons and bullets).
    Additionally, he has a keen interest in medical diagnostics using PCR and museology in medicine.

Awards and Recognition 🏆

Although specific awards are not listed, Professor Dobosz’s prolific contributions to molecular genetics and forensic science have established him as a leader in his field. His Hirsch Index of 20 underscores the impact of his work in the scientific community.

Publications 📚

  • “PPARs in Clinical Experimental Medicine after 35 Years of Worldwide Scientific Investigations and Medical Experiments”
    • Authors: Skoczyńska, A.; Ołdakowska, M.; Dobosz, A.; Małodobra-Mazur, M.; Dobosz, T.
    • Year: 2024
    • Citations: 1
  • “DNA Content of Various Fluids and Tissues of the Human Body”
    • Authors: Siuta, J.; Dobosz, A.; Kawecki, J.; Dobosz, T.
    • Year: 2024
    • Citations: 2
  • “The hero of American and Polish nations: a molecular look at Thaddeus Kosciuszko’s cause of death suggests a contribution of endocarditis caused by Cutibacterium acnes infection”
    • Authors: Witt, M.; Tokarski, M.; Ziętkiewicz, E.; Jurek, T.; Dobosz, T.
    • Year: 2022
    • Citations: 0
  • “Analysis of polymorphism in 11 STR markers in the European red deer (Cervus elaphus) population in Poland”
    • Authors: Jonkisz, A.; Lebioda, A.; Cierzniak, A.; Dobosz, T.; Małodobra-Mazur, M.
    • Year: 2022
    • Citations: 0
  • “Inheritance vs. infectivity as a mechanism of malady and death of Frederic Chopin”
    • Authors: Witt, M.; Dobosz, T.
    • Year: 2021
    • Citations: 3
  • “Histone modifications influence the insulin-signaling genes and are related to insulin resistance in human adipocytes”
    • Authors: Małodobra-Mazur, M.; Cierzniak, A.; Myszczyszyn, A.; Kaliszewski, K.; Dobosz, T.
    • Year: 2021
    • Citations: 12
  • “PpMolecular Medicinearg hypermethylation as the first epigenetic modification in newly onset insulin resistance in human adipocytes”
    • Authors: Małodobra-Mazur, M.; Cierzniak, A.; Kaliszewski, K.; Dobosz, T.
    • Year: 2021
    • Citations: 15
  • “DNA methylation in adipocytes from visceral and subcutaneous adipose tissue influences insulin-signaling gene expression in obese individuals”
    • Authors: Cierzniak, A.; Pawelka, D.; Kaliszewski, K.; Dobosz, T.; Małodobra-Mazur, M.
    • Year: 2021
    • Citations: 12
  • “Original and generic clopidogrel: A comparison of antiplatelet effects and active metabolite concentrations in patients without polymorphisms in the ABCB1 gene and the allele variants CYPC192 and 3″
    • Authors: Wójcik, T.; Szymkiewicz, P.; Ściborski, K.; Jonkisz, A.; Protasiewicz, M.
    • Year: 2021
    • Citations: 2
  • “Metabolic differences between subcutaneous and visceral adipocytes differentiated with an excess of saturated and monounsaturated fatty acids”
    • Authors: Małodobra-Mazur, M.; Cierzniak, A.; Pawełka, D.; Rudnicki, J.; Dobosz, T.
    • Year: 2020
    • Citations: 27

Conclusion ✨

Tadeusz Dobosz has left an indelible mark on forensic science, molecular biology, and medical genetics. From pioneering DNA sequencing techniques to advancing paternity testing and forensic genetics, his work has significantly impacted these fields. Even in retirement, his passion for medicine and science continues through his dedication to museology, ensuring that future generations benefit from his expertise and vision.